… Irritable bowel syndrome (IBS) is the most recognized and researched of the DGBI. In this
article, available data on classical epidemiologic questions, such as the prevalence of IBS and …

… comparisons between multiple countries simultaneously and, as such, is likely to be
important in advancing our understanding of the epidemiology of IBS from a global perspective. …

… , liver diseases, inflammatory bowel disease, celiac disease, and functional gastrointestinal
disorders, like dyspepsia and irritable bowel syndrome. Digestive cancers are strongly age-…

… Proportions of subjects with irritable bowel syndrome were lower when the Rome IV criteria
were used, compared with the Rome III criteria, in the Internet survey (4.1% vs 10.1%) and …

… Preference toward global IBS treatments including central … -effective from an insurer
perspective despite a lower level of … fail global IBS treatments, who are poor candidates for global …

… Background: There are about 10–23% of adults worldwide suffering from irritable bowel
syndrome (IBS). Over the past few decades, there are many aspects of uncertainty regarding IBS …

… Core Tip: This is the first study to evaluate and quantify the global research productivity
pertaining to the microbiome in irritable bowel syndrome (IBS). We present a holistic picture of …

… Crohn’s disease and ulcerative colitis have emerged as global … to provide globally sustainable
inflammatory bowel disease … , inflammatory bowel disease (IBD) has emerged as a global …

Background Inflammatory bowel diseases (IBD), including Crohn disease (CD) and
ulcerative colitis (UC), are complex disorders with multiple comorbidities. We conducted …

… QOL detection technology involves the direct involvement of the patient (World Gastroenterology
Organization global guidelines irritable bowel syndrome: a global perspective, 2015). …